| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_146d4d5e53b40ab922b814200a5f6bb0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba7b273fc2c9a15462edee69a5de582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f081882efa9c7612bbfd7f4396d73e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ecc7f61b8f207e1fbea7d9c08c17caf |
| publicationDate |
2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3964196-A1 |
| titleOfInvention |
Use of chlorhexidine and cetylpyridinium chloride as antiviral agents |
| abstract |
The invention relates to the use of a composition comprising (a) 0.01 - 0.3 wt.-% chlorhexidine, (b) 0.02 - 0.2 wt.-% cetylpyridinium chloride and (c) 0.1 - 1.0 wt.-% of a surface active agent in water as antiviral agent in the oral cavity. The invention further relates to a process for reducing the number of active viruses in the oral cavity, comprising administering to the oral cavity an effective amount of the composition. |
| priorityDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |